Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses

BACKGROUND: Immunomodulatory/immunosuppressive activity of multiple sclerosis (MS) disease modifying therapies (DMTs) might affect immune responses to SARS-CoV-2 exposure or vaccination in patients with MS (PwMS). We evaluated the effect of DMTs on humoral and cell-mediated immune responses to 2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Milo, Ron, Staun-Ram, Elsebeth, Karussis, Dimitrios, Karni, Arnon, Hellmann, Mark A., Bar-Haim, Erez, Miller, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012137/
https://www.ncbi.nlm.nih.gov/pubmed/35432335
http://dx.doi.org/10.3389/fimmu.2022.868915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012137/
https://www.ncbi.nlm.nih.gov/pubmed/35432335
http://dx.doi.org/10.3389/fimmu.2022.868915

Ejemplares similares